FNY Partners Fund’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,000
Closed -$136K 989
2017
Q1
$136K Buy
+3,000
New +$130K 0.02% 422

Other funds holding PCRX

FNY Partners Fund's PCRX Position: Q2 2017 in Review

FNY Partners Fund sold out of Pacira BioSciences (PCRX) in Q2 2017, closing a stake of 3,000 shares — an estimated $136K sold.

FNY Partners Fund first reported a position in PCRX in Q1 2017 and held it in 1 quarter. The position peaked at $136K in Q1 2017. 196 funds tracked by Wall St. Rank hold PCRX as of Q2 2017.

  • FNY Partners Fund reported no remaining Pacira BioSciences position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 3,000 Pacira BioSciences shares in Q2 2017, an estimated $136K.
  • FNY Partners Fund first reported a position in Pacira BioSciences in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Pacira BioSciences position peaked at $136K in Q1 2017.
  • 196 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.